Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib + OxyContin + pregabalin for cancerous pudendal neuralgia
ChiCTR2100046045Phase 4Completed
- Sponsor
- Jilin Provincial People's Hospital
- Start
- Jun 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pudendal neuralgia (PN) comparing celecoxib + OxyContin + pregabalin with Control: OxyContin + pregabalin (2 arms). Primary endpoint: NRS pain score. Started Jun 2019; status: completed.
02
Drugs
celecoxiboxycodonepregabalin
03
Conditions
pudendal neuralgia (PN)
Beyond the preview
Go deeper on ChiCTR2100046045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046045.